(
EMAILWIRE.COM, August 22, 2018 ) Europe Erythropoietin Drugs Market was worth USD 3.39 billion in 2018 and estimated to be growing at a CAGR of 9.5%, to reach USD 5.33 billion by 2023.
Erythropoietin is present in the bone marrow cells controlling the production of red blood cells. They can be used for the treatment of anaemia, HIV and Cancer. Various synthetic forms of erythropoietin are available in the market due to advancements in recombinant DNA technology.
Browse full report @
https://www.marketdataforecast.com/market-reports/europe-erythropoietin-drugs-market-6770/Increased incidence of anaemia, rising commercialisation of EPO drugs and favourable reimbursement policies are further driving the market growth. As cheaper biosimilars are also available the market is expected to propel during the forecast period.
Request sample report @
Market Segmentation
Product
Introduction
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Application
Introduction
Cancer
Hematology
Renal diseases
Drug class
Introduction
Biologics
Biosimilars
Inquire before buying @
https://www.marketdataforecast.com/market-reports/europe-erythropoietin-drugs-market-6770/inquire The market for Erythropoietin Drugs is broadly categorized into product, application and drug class. By product the market is divided into Epoetin-alpha, epoetin-beta, darbepoetin-alfa and others. Epoietin-alfa holds the largest market share. By application the market is classified into cancer, haematology, renal diseases and neurology. Cancer segment is predicted to be fastest growing segment. By drug class the market is segmented into biologics and biosimilar. Biosimilars are predicted to grow at a significant rate during the forecast period. On the basis of geography, the market is analysed under various regions namely U.K, Germany, Italy, France and Spain. The Erythropoietin Drugs market was dominated by Europe.
Request discount @
https://www.marketdataforecast.com/market-reports/europe-erythropoietin-drugs-market-6770/request-discountSome of the major companies dominating the market, by their products and services include Johnson & Johnson, Celltrion, Inc, Teva Pharmaceutical Industries Ltd. , Sun Pharmaceutical Industries Ltd. , Dr. Reddy’s Laboratories Ltd.Amgen, Inc. , F. Hoffmann-La Roche Ltd. , LG Life Sciences Ltd. , Biocon Limited and Intas Pharmaceuticals Ltd.
Buy full report @
https://www.marketdataforecast.com/cart/buy-now/europe-erythropoietin-drugs-market-6770
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.comSource:
EmailWire.Com